Samjin Pharmaceuticals financial statements

삼진제약KRX:005500 · KOSPI · Healthcare · sector #23
₩19,760+2.28%
2026-10-07 close

Samjin Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was KRW 308.35B. 2024 operating profit was KRW 31.53B.

Reported results

Samjin Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q